Neurological and brain-related cancers are one of the main causes of death worldwide. A commonly used tool in diagnosing these conditions is Magnetic Resonance Imaging (MRI), yet the manual evaluation of MRI images by medical experts presents difficulties due to time constraints and variability. This research introduces a novel, two-module computerized method aimed at increasing the speed and accuracy of brain tumor detection. The first module, termed the Image Enhancement Technique, utilizes a trio of machine learning and imaging strategies—adaptive Wiener filtering, neural networks, and independent component analysis—to normalize images and combat issues such as noise and varying low region contrast. The second module uses Support Vector Machines to validate the output of the first module and perform tumor segmentation and classification. Applied to various types of brain tumors, including meningiomas and pituitary tumors, our method exhibited significant improvements in contrast and classification efficiency. It achieved an average sensitivity and specificity of 0.991, accuracy of 0.989, and a Dice score (DSC) of 0.981. Furthermore, the processing time of our method, averaging at 0.43 seconds, was markedly lower compared to existing methods. These results underscore the superior performance of our approach over current state-of-the-art methods in terms of sensitivity, specificity, precision, and DSC. Future enhancements will seek to increase the robustness of the tumor classification method by employing a standardized approach across a suite of classifiers.

Brain tumor classification is essential for clinical diagnosis and treatment planning. Deep learning models have shown great promise in this task, but they are often challenged by the complex and diverse nature of brain tumors. To address this challenge, we propose a novel deep residual and region-based convolutional neural network (CNN) architecture, called Res-BRNet, for brain tumor classification using magnetic resonance imaging (MRI) scans. Res-BRNet employs a systematic combination of regional and boundary-based operations within modified spatial and residual blocks. The spatial blocks extract homogeneity, heterogeneity, and boundary-related features of brain tumors, while the residual blocks significantly capture local and global texture variations. We evaluated the performance of Res-BRNet on a challenging dataset collected from Kaggle repositories, Br35H, and figshare, containing various tumor categories, including meningioma, glioma, pituitary, and healthy images. Res-BRNet outperformed standard CNN models, achieving excellent accuracy (98.22%), sensitivity (0.9811), F1-score (0.9841), and precision (0.9822). Our results suggest that Res-BRNet is a promising tool for brain tumor classification, with the potential to improve the accuracy and efficiency of clinical diagnosis and treatment planning.

Nowadays, brain tumors have become a leading cause of mortality worldwide. The brain cells in the tumor grow abnormally and badly affect the surrounding brain cells. These cells could be either cancerous or non-cancerous types, and their symptoms can vary depending on their location, size, and type. Due to its complex and varying structure, detecting and classifying the brain tumor accurately at the initial stages to avoid maximum death loss is challenging. This research proposes an improved fine-tuned model based on CNN with ResNet50 and U-Net to solve this problem. This model works on the publicly available dataset known as TCGA-LGG and TCIA. The dataset consists of 120 patients. The proposed CNN and fine-tuned ResNet50 model are used to detect and classify the tumor or no-tumor images. Furthermore, the U-Net model is integrated for the segmentation of the tumor regions correctly. The model performance evaluation metrics are accuracy, intersection over union, dice similarity coefficient, and similarity index. The results from fine-tuned ResNet50 model are IoU: 0.91, DSC: 0.95, SI: 0.95. In contrast, U-Net with ResNet50 outperforms all other models and correctly classified and segmented the tumor region.

This paper presents a comprehensive study on the classification of brain tumor images using five pre-trained vision transformer (ViT) models, namely R50-ViT-l16, ViT-l16, ViT-l32, ViT-b16, and ViT-b32, employing a fine-tuning approach. The objective of this study is to advance the state-of-the-art in brain tumor classification by harnessing the power of these advanced models. The dataset utilized for experimentation consists of a total of 4855 images in the training set and 857 images in the testing set, encompassing four distinct tumor classes. The performance evaluation of each model is conducted through an extensive analysis encompassing precision, recall, F1-score, accuracy, and confusion matrix metrics. Among the models assessed, ViT-b32 demonstrates exceptional performance, achieving a high accuracy of 98.24% in accurately classifying brain tumor images. Notably, the obtained results outperform existing methodologies, showcasing the efficacy of the proposed approach. The contributions of this research extend beyond conventional methods, as it not only employs cutting-edge ViT models but also surpasses the performance of existing approaches for brain tumor image classification. This study not only demonstrates the potential of ViT models in medical image analysis but also provides a benchmark for future research in the field of brain tumor classification.

Accurate classification of brain tumors is essential for effective medical diagnosis and treatment planning. Traditional approaches rely on convolutional neural networks (CNNs) for tumor detection, but they often suffer from high computational demands due to the large number of parameters. In this paper, we propose a novel approach for brain tumor classification using involutional neural networks (InvNets), which are designed to mitigate the parameter-intensive nature of CNNs. Unlike the spatial-agnostic and channel-specific convolution kernel, the involution kernel is location-specific and channel-agnostic. This location-specific operation allows the network to adapt to various visual patterns with respect to different spatial locations, enhancing its ability to capture intricate features within the medical images. Our study focuses on a four-class brain tumor classification problem, aiming to differentiate between different tumor types based on medical imaging data. In a comparative analysis, we demonstrate that conventional CNNs require over 4 million parameters, whereas our proposed InvNets require less than 0.2 million parameters, making them more efficient and resource-friendly. The evaluation of both CNNs and InvNets is carried out using standard performance matrices: accuracy, precision, recall, F1 score, and AUC-ROC values. Our findings reveal that the InvNets consistently outperform traditional CNNs. The InvNet architecture achieves an impressive 92% accuracy rate, showcasing its potential for accurate brain tumor classification. This improved accuracy, combined with the reduced parameter count, highlights the effectiveness of InvNets for medical image analysis tasks, especially in scenarios with limited computational resources.

Background: Prostate cancer is a leading cause of cancer-related deaths in men worldwide, making accurate diagnosis critical for effective treatment. Recent advancements in artificial intelligence (AI) and machine learning (ML) have shown promise in improving the diagnostic accuracy of prostate cancer. Objectives: This systematic review aims to evaluate the effectiveness of AI-based tools in diagnosing prostate cancer using MRI, with a focus on accuracy, specificity, sensitivity, and clinical utility compared to conventional diagnostic methods. Methods: A comprehensive search was conducted across PubMed, Embase, Ovid MEDLINE, Web of Science, Cochrane Library, and Institute of Electrical and Electronics Engineers (IEEE) Xplore for studies published between 2019 and 2024. Inclusion criteria focused on full-text, English-language studies involving AI for Magnetic Resonance Imaging (MRI) -based prostate cancer diagnosis. Diagnostic performance metrics such as area under curve (AUC), sensitivity, and specificity were analyzed, with risk of bias assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. Results: Seven studies met the inclusion criteria, employing various AI techniques, including deep learning and machine learning. These studies reported improved diagnostic accuracy (with AUC scores of up to 97%) and moderate sensitivity, with performance varying based on training data quality and lesion characteristics like Prostate Imaging Reporting and Data System (PI-RADS) scores. Conclusions: AI has significant potential to enhance prostate cancer diagnosis, particularly when used for second opinions in MRI interpretations. While these results are promising, further validation in diverse populations and clinical settings is necessary to fully integrate AI into standard practice.